Hepatectomy Group:Hepatectomy

4 trials

Sponsors

FuJian Provincial Hospital, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Shanghai Eastern Hepatobiliary Hospital, Fujian Provincial Hospital

Conditions

Hepatocellular carcinomaIPMN-Bhepatocellular carcinomahuge hepatocellular carcinoma

Early Phase 1

A Clinical study on the establishment of treatment protocol for huge hepatocellular carcinoma based on individualized prognosis prediction

Active, not recruitingChiCTR2000036873

Shanghai Eastern Hepatobiliary Hospitalhuge hepatocellular carcinoma

Start: 2020-10-01Updated: 2020-09-21

Phase 2

A prospective randomized controlled trial of neoadjuvant therapy with TACE, lenvatinib and camrelizumab versus surgical resection alone for resectable HCC patients with type I / II PVTT

Active, not recruitingChiCTR2300069972

Fujian Provincial Hospitalhepatocellular carcinoma

Start: 2023-04-01Updated: 2023-05-29

Unknown Phase

A case records based retrospective study for factors influencing prognosis of patients with Intraductal Papillary Mucinous Neoplasm of the Bile Duct

Active, not recruitingChiCTR1900020982

FuJian Provincial HospitalIPMN-B

Start: 2019-02-01Updated: 2019-01-28

A randomized controlled trial of hepatectomy vesus transcatheter arterial chemoembolization for UICC T3 hepatocellular carcinoma

Active, not recruitingChiCTR2000033549

The First Affiliated Hospital of Guangzhou University of Chinese MedicineHepatocellular carcinoma

Start: 2020-06-15Updated: 2020-06-08